Medical Device | January 06, 2022
Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
2022 is going to be the year of opportunities and innovations from the medical industry in India
KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
The company plans to expand their capacity to meet the needs of pharma and biotech industries
It plans to add over 1000 employees over the next six months
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
Hospitals and outpatient clinics can also digitally navigate patients from the time an order is placed, to when it is scheduled and completed through follow-up
Subscribe To Our Newsletter & Stay Updated
